Cencora, Inc. (LON:0HF3)
351.18
+5.42 (1.57%)
At close: Nov 5, 2025
Cencora Revenue
In the fiscal year ending September 30, 2025, Cencora had annual revenue of $321.33B USD with 9.31% growth. Cencora had revenue of $83.73B in the quarter ending September 30, 2025, with 5.92% growth.
Revenue
$321.33B
Revenue Growth
+9.31%
P/S Ratio
0.22
Revenue / Employee
$6.99M
Employees
46,000
Market Cap
52.63B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 321.33B | 27.37B | 9.31% |
| Sep 30, 2024 | 293.96B | 31.79B | 12.12% |
| Sep 30, 2023 | 262.17B | 23.59B | 9.89% |
| Sep 30, 2022 | 238.59B | 24.60B | 11.50% |
| Sep 30, 2021 | 213.99B | 24.09B | 12.69% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Cencora News
- 21 days ago - IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes - Business Wire
- 22 days ago - The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage. - Barrons
- 4 weeks ago - Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release - Business Wire
- 2 months ago - Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 months ago - Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Cencora Appoints Mark Durcan as Chairman of Its Board of Directors - Business Wire
- 3 months ago - Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap - Seeking Alpha